Keywords: Canada, Clinical trials system, Transparency, Senate committee, Rx&D

Canadian Senate committee finds faults in current clinical trials system

Article | 05 November 2012

The absence of a standardized approach to research ethics review significantly impacts the time required to start up clinical trials ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in